Iterum Therapeutics's market cap is currently $51.53M. The company's EPS TTM is $-1.312; its P/E ratio is ―; Iterum Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -254.00K	$ -1.75M	$ -1.80M	$ -2.10M	$ -161.00K
Operating Income	$ -18.70M	$ -47.47M	$ -30.38M	$ -24.54M	$ -32.13M
EBITDA	$ -18.70M	$ -34.58M	$ -39.97M	$ -83.20M	$ -36.01M
Net Income	$ -24.77M	$ -38.37M	$ -44.43M	$ -91.56M	$ -52.01M
Balance Sheet
Cash & Short-Term Investments	$ 24.13M	$ 23.93M	$ 60.84M	$ 81.34M	$ 14.51M
Total Assets	$ 44.59M	$ 26.26M	$ 66.83M	$ 91.51M	$ 32.79M
Total Debt	$ 45.53M	$ 18.96M	$ 28.47M	$ 24.90M	$ 35.85M
Net Debt	$ 21.41M	$ 12.88M	$ 7.37M	$ -2.55M	$ 21.34M
Total Liabilities	$ 48.68M	$ 32.66M	$ 38.83M	$ 41.27M	$ 83.35M
Stockholders' Equity	$ -4.08M	$ -6.40M	$ 28.00M	$ 50.23M	$ -50.56M
Cash Flow
Free Cash Flow	$ -26.77M	$ -39.34M	$ -18.54M	$ -15.90M	$ -54.54M
Operating Cash Flow	$ -26.77M	$ -39.33M	$ -18.47M	$ -15.84M	$ -54.53M
Investing Cash Flow	$ 18.21M	$ 23.34M	$ 13.96M	$ -54.59M	$ -11.00K
Financing Cash Flow	$ 26.69M	$ 1.03M	$ -1.82M	$ 83.13M	$ 64.47M

Currency in USD

Iterum Therapeutics Earnings and Revenue History

Income Statement >

Iterum Therapeutics Debt to Assets

Balance Sheet >

Iterum Therapeutics Cash Flow

Cash Flow >

Iterum Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing